X

BIIB

Biogen Inc (BIIB) Sec Form 8K

Biogen Inc (NASDAQ: BIIB) Sec Form 8K

Biogen Inc (BIIB) Biogen Announces Board Chair Transition

Biogen Inc (NASDAQ: BIIB) FY 2026 Management Update

Biogen Inc (BIIB) Sec Form 10K

Biogen Inc (NASDAQ: BIIB) Sec Form 10K

Biogen Inc (BIIB) Sec Form 8K

Biogen Inc (NASDAQ: BIIB) Sec Form 8K

Biogen Shares Rise on Q4 Earnings Beat Despite Lower Revenue Outlook

Shares of Biogen Inc (BIIB) rose 8.53% to $201.18 at close on Friday following the release of fourth-quarter and full-year…

Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7%

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower revenues and adjusted earnings for the fourth quarter of fiscal 2025. The…

Biogen Inc (BIIB) Q4 2025 Earnings Call

Biogen Inc (NASDAQ: BIIB) Q4 2025 Earnings Conference

Biogen Inc (BIIB) Q4 2025 Earnings Call Transcript

Biogen Inc (NASDAQ: BIIB) Q4 2025 Earnings Call dated Feb. 12, 2025 Corporate Participants: Tim Power — Head of Investor…

Biogen Inc (BIIB) Q2 2025 Earnings Call Transcript

Biogen Inc (NASDAQ: BIIB) Q2 2025 Earnings Call dated Jul. 31, 2025 Corporate Participants: Tim Power — Head of Investor…

Biogen Inc (BIIB) Q3 2025 Earnings Call Transcript

Biogen Inc (NASDAQ: BIIB) Q3 2025 Earnings Call dated Oct. 30, 2025 Corporate Participants: Tim Power — Head of Investor…